Gladstone NOW: The Campaign Join Us on the Journey✕
106 - 120 of 1256 Results Clear All
This distinction recognizes his and the institute’s pioneering blend of genomics and immunology toward the design and improvement of cancer immunotherapy
Institutional News Genomic Immunology Marson Lab
How gene editing and stem cells are working in tandem at Gladstone Institutes to change science and medicine
Deep Dive Stem Cells/iPSCs CRISPR/Gene Editing Srivastava Lab Yamanaka Lab Doudna Lab Conklin Lab Marson Lab Huang Lab Ott Lab
Marty Yang shares the path that led him to Gladstone, his future career goals, and how he wishes he could have a conversation with Charlie, his goldendoodle.
Graduate Students and Postdocs Profile Ramani Lab
Gladstone provides additional support to postdocs, particularly those with children
Graduate Students and Postdocs
PharmaVoice—PharmaVoice recently assembled its annual list of inspiring leaders in the industry. Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, was named to the list as a cancer care visionary, recognized for both his scientific innovation and his dedication to collaboration and mentoring.
Gladstone Experts Genomic Immunology Marson Lab
UCSF News—Gladstone Senior Investigators Alex Marson and Jennifer Doudna, and President of the UC San Francisco Helen Diller Family Comprehensive Cancer Center Alan Ashworth, will head the newly launched CRISPR Cures for Cancer Initiative, which will fund research at the intersection of genomic technologies and cellular immunotherapies at Gladstone Institutes, UC San Francisco, and the Innovative Genomics Institute at UC Berkeley.
Gladstone Experts Cancer Data Science and Biotechnology Genomic Immunology Doudna Lab Marson Lab CRISPR/Gene Editing Stem Cells/iPSCs
Scientists used a new method to screen 10,000 combinations of gene edits in immune cells engineered to fight cancer
News Release Research (Publication) Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing
An 8-year-old with CMT meets with Gladstone researchers
Gladstone Experts Conklin Lab
Alzforum—Loss of synapses in the brain is associated with progression of Alzheimer’s disease. However, a new study led by Lennart Mucke, director of the Gladstone Institute of Neurological Disease, shows that in mice, a mutation associated with increased risk of Alzheimer’s disease results in an excess of synapses. In conjunction with recent work from a few other groups, this suggests that removal of synapses may actually play a protective role against Alzheimer’s, at least early in the disease process.
Gladstone Experts Alzheimer’s Disease Neurological Disease Mucke Lab
Jillian Goldstein, Gladstone's in-house therapist, explains how you can help a colleague who is going through a mental health challenge
Counseling and Wellness Center
Andrew C. Yang joins Gladstone Institutes to decode the cross talk between the brain and body in aging and neurodegeneration
Institutional News News Release Alzheimer’s Disease Neurological Disease Yang Lab
New study explains how understudied cells in the immune system, called gamma delta T cells, can target cancer cells for destruction
News Release Research (Publication) Cancer Genomic Immunology Marson Lab
Photo highlights from the 2023 PUMAS Internship
Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Students and Postdocs
A new tool created by Gladstone researchers aligns data from tissue slices virtually, expanding possibilities for 3D analysis
News Release Research (Publication) Data Science and Biotechnology Engelhardt Lab Big Data
Watch a demo to learn how to make your slide presentations stand out.
Communications
